Correlation Network, together with a number of partners, organised a Hepatitis C Community Summit in April 2017 in Amsterdam, because this is a historic moment for Hepatitis C treatment. With the advent of direct-acting antivirals (DAAs) we can now massively reduce the harm from an infectious disease that affects millions of people and causes hundreds of thousands of unnecessary deaths every year. Interferon-free DAA regimes are short, highly tolerable, and simple to deliver, with cure rates of over 90%.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: Flickr CC AJC1